Silencing of endo-exonuclease expression sensitizes mouse B16F10 melanoma cells to DNA damaging agents
Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide
In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression
Dimethylamino-functionalised and N-heteroaryl-substituted titanocene anticancer drugs: : Synthesis and cytotoxicity studies
Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatin
Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)
A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors
Docetaxel-ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclines
Phase II study of Triapine® in patients with metastatic renal cell carcinoma: : A trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161)
The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: : A phase II study
Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors
Effects of dutasteride on the expression of genes related to androgen metabolism and related pathway in human prostate cancer cell lines
Amrubicin for non-small-cell lung cancer and small-cell lung cancer